BAM66442
BMS-599626
BMS-599626 is a highly selective pan-HERKinase inhibitor with IC50 of 20 and 30 nM for the inhibition of HER1and HER2, respectively.
|
Quantity
Price
5 mg
160.00
10 mg
250.00
50 mg
750.00
200 mg
1800.00
|
|
C27H27FN8O3
|
8173837-23-1
|
98+%
|
MFCD10565678
|
|
BAM66442
AC480
BMS-599626 is a highly selective pan-HERKinase inhibitor with IC50 of 20 and 30 nM for the inhibition of HER1and HER2, respectively.
|
Quantity
Price
5 mg
160.00
10 mg
250.00
50 mg
750.00
200 mg
1800.00
|
|
C27H27FN8O3
|
8173837-23-1
|
98+%
|
MFCD10565678
|
|
BAM66443
BIBW-2992
BIBW-2992 is a potent, irreversible, orally active inhibitor of the epidermal growth factor receptor EGFR and HER2 with an IC50’s of 0.5 nM and 14 nM, respectively.
|
Quantity
Price
10 mg
75.00
50 mg
280.00
100 mg
490.00
200 mg
780.00
500 mg
1770.00
|
|
C24H25ClFN5O3
|
439081-18-2
|
98+%
|
MFCD12407405
|
|
BAM66443
Afatinib
BIBW-2992 is a potent, irreversible, orally active inhibitor of the epidermal growth factor receptor EGFR and HER2 with an IC50’s of 0.5 nM and 14 nM, respectively.
|
Quantity
Price
10 mg
75.00
50 mg
280.00
100 mg
490.00
200 mg
780.00
500 mg
1770.00
|
|
C24H25ClFN5O3
|
439081-18-2
|
98+%
|
MFCD12407405
|
|
BAM66443
Tovok
BIBW-2992 is a potent, irreversible, orally active inhibitor of the epidermal growth factor receptor EGFR and HER2 with an IC50’s of 0.5 nM and 14 nM, respectively.
|
Quantity
Price
10 mg
75.00
50 mg
280.00
100 mg
490.00
200 mg
780.00
500 mg
1770.00
|
|
C24H25ClFN5O3
|
439081-18-2
|
98+%
|
MFCD12407405
|
|
|